Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based PerkinElmer has appointed Robert Friel, the company's president and CEO, to the additional role of chairman of the board of directors.
Subscribe to our email newsletter
The appointment of Mr Friel to chairman is believed to be part of PerkinElmer’s 2007 leadership succession plan designed to support the company’s growth strategy and provide strong leadership continuity. Mr Friel succeeds Gregory Summe, chairman since 1999, who did not stand for reelection.
Mr Friel joined PerkinElmer in 1999 as CFO and was appointed vice chairman and president of the company’s life and analytical sciences business in 2006. In 2007, Mr Friel was appointed president and COO of the company. Mr Friel succeeded Mr Summe as CEO in 2008.
Mr Friel said: “Greg’s vision, commitment and strong leadership over the last decade have been instrumental in transforming PerkinElmer from a diversified company with an offering largely focused in government services, to a $2 billion global technology and health sciences leader.
“We will leverage our strong operating foundation to continue expanding our human and environmental health businesses and broadening our footprint in emerging markets. We thank Greg for all of his contributions to the company.”